A breast cancer drug from Roche known as Perjeta helped patients live nearly 16 months longer compared with Herceptin and chemotherapy alone. CNBC's Meg Tirrell provides insight to the data.» Read More
How much do you know about the costs and rewards of education?
In his new book, "SHINE: Using Brain Science to Get the Best from Your People," author and psychiatrist Dr. Ned Hallowell explains how the latest research in brain science, yes BRAIN SCIENCE, can help motivate and engage employees to become top performers.
Sunspots are moving in direct correlation with activity in the markets and they are predicting a crisis in about three years, technical analyst Charles Nenner told CNBC Monday.
A new photonic chip that works on light rather than electricity has been built by an international research team, paving the way for the production of ultra-fast quantum computers with capabilities far beyond today’s devices.
President Obama faces a messy political fight over the federal court ruling striking down his new, looser policy letting federal grant money pay for stem cell research involving “destroyed” embryos.
Two reports published Friday offer novel approaches to the age-old dream of regenerating the body from its own cells.
A spacecraft designed to rocket wealthy tourists into space as early as 2011 was unveiled Monday in what backers of the venture hope will signal a new era in aviation history.
Britain's military has closed a hotline that took reports of unidentified flying objects, or UFOs.
Author and brain scientist Jeffrey Stibel writes in 'WIRED FOR THOUGHT How The Brain is Shaping the Future' that business leaders must think of the Internet as a 'thinking machine' - the first real replication of the human brain OUTSIDE the human body.
Virtually every large pharmaceutical company seems to have discovered cancer, and a substantial portion of the smaller biotechnology companies are focused on it as well. Together, the companies are pouring billions of dollars into developing cancer drugs.
Sustainability isn’t just about saving the planet. It's about opportunity—reinventing business models to better compete in the global economy.
Yeah, right. Actually, the working sessions and panels are better attended than any conference I've ever seen.
Joe's pee smells after he eats asparagus. That's what he announced to me, and the rest of the world, on Squawk this morning.
While we're spending hundreds of billions to bail out financial institutions, why not also bail in the future by investing more in science and technology?
Do you know where your federal income-tax dollars go? The National Priorities Project does. Learn how each dollar is spent when it gets into Uncle Sam's hands.
Swiss drugmaker Roche has submitted its experimental Actemra drug to the U.S. authorities for approval to treat moderate to severe rheumatoid arthritis in adults.
Medical device maker Boston Scientific is preparing to slash thousands of jobs to counter slumping sales, according to a media report Tuesday.
Americans Leonid Hurwicz, Eric Maskin and Roger Myerson won the Nobel Memorial Prize in Economic Sciences on Monday for their work that "laid the foundations of mechanism design theory."
EU farm ministers fell short of a consensus agreement on Wednesday to allow imports of three genetically modified (GMO) maize types, again revealing their deep differences on GMO crops and foods, officials said.